Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model (2015)
Source: Brazilian Journal of Medical and Biological Research. Unidades: FMVZ, FM
Subjects: ANTINEOPLÁSICOS, HEPATOPATIAS, MODELOS ANIMAIS DE DOENÇAS
ABNT
STEFANO, José Tadeu et al. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model. Brazilian Journal of Medical and Biological Research, v. 48, n. 5, p. 408-414, 2015Tradução . . Disponível em: https://doi.org/10.1590/1414-431X20143962. Acesso em: 17 ago. 2024.APA
Stefano, J. T., Pereira, I. V. A., Torres, M. M., Bida, P. M., Coelho, A. M. M., Xerfan, M. P., et al. (2015). Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model. Brazilian Journal of Medical and Biological Research, 48( 5), 408-414. doi:10.1590/1414-431X20143962NLM
Stefano JT, Pereira IVA, Torres MM, Bida PM, Coelho AMM, Xerfan MP, Cogliati B, Barbeiro DF, Mazo DF de C, Kubrusly MS, D’Albuquerque LAC, Souza HP de, Carrilho FJ, Oliveira CP de. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 408-414.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1590/1414-431X20143962Vancouver
Stefano JT, Pereira IVA, Torres MM, Bida PM, Coelho AMM, Xerfan MP, Cogliati B, Barbeiro DF, Mazo DF de C, Kubrusly MS, D’Albuquerque LAC, Souza HP de, Carrilho FJ, Oliveira CP de. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 408-414.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1590/1414-431X20143962